Howe & Rusling’s Illumina ILMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-13
Closed -$2K 657
2022
Q3
$2K Sell
13
-62
-83% -$12.3K ﹤0.01% 872
2022
Q2
$13K Sell
75
-543
-88% -$139K ﹤0.01% 494
2022
Q1
$210K Sell
618
-118
-16% -$39.9K 0.02% 200
2021
Q4
$272K Sell
736
-104
-12% -$39.4K 0.03% 178
2021
Q3
$331K Hold
840
0.04% 149
2021
Q2
$387K Hold
840
0.05% 132
2021
Q1
$314K Sell
840
-7,367
-90% -$3M 0.04% 137
2020
Q4
$2.95M Buy
8,207
+624
+8% +$199K 0.45% 62
2020
Q3
$2.28M Buy
+7,583
New +$2.61M 0.39% 62
2015
Q4
Sell
-10
Closed -$2K 1030
2015
Q3
$2K Hold
10
﹤0.01% 826
2015
Q2
$2K Hold
10
﹤0.01% 863
2015
Q1
$2K Buy
+10
New +$1.88K ﹤0.01% 771

Other funds holding ILMN

Howe & Rusling's ILMN Position: Q4 2022 in Review

Howe & Rusling sold out of Illumina (ILMN) in Q4 2022, closing a stake of 13 shares — an estimated $2K sold.

Howe & Rusling first reported a position in ILMN in Q1 2015 and held it in 12 quarters. The position peaked at $2.95M in Q4 2020. 943 funds tracked by Wall St. Rank hold ILMN as of Q4 2022.

  • Howe & Rusling reported no remaining Illumina position as of Q4 2022 after selling out during the quarter.
  • Howe & Rusling sold 13 Illumina shares in Q4 2022, an estimated $2K.
  • Howe & Rusling first reported a position in Illumina in Q1 2015 and held it in 12 quarters.
  • Howe & Rusling's Illumina position peaked at $2.95M in Q4 2020.
  • 943 funds tracked by Wall St. Rank held Illumina as of Q4 2022.

Based on Howe & Rusling's 13F filing for Q4 2022, filed 15 Feb 2023.